Clincosm LogoSign in Get a demo

Diffuse Large B Cell Lymphoma

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

CLL/SLL, NHL, Mantle Cell Lymphoma Trial in United States (SYNCAR-001, STK-009, Cyclophosphamide)

Recruiting
  • CLL/SLL
  • +6 more
  • Duarte, California
  • +4 more
Jan 12, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Nov 29, 2022

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in United Kingdom, United States (AUTO3)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • AUTO3
  • Duarte, California
  • +10 more
Oct 19, 2022

Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Buparlisib, Ibrutinib)

Completed
  • Lymphoma
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Oct 7, 2022

Lenalidomide Monotherapy in R/R DLBCL

Completed
  • Diffuse Large B Cell Lymphoma
    • Rochester, Minnesota
    • +56 more
    Aug 23, 2022

    Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

    Terminated
    Has Results
    • Non-Hodgkin's B-cell Lymphoma
    • +5 more
    • MT-3724 Phase 1
    • MT-3724 Phase 2
    • Tucson, Arizona
    • +40 more
    Jul 18, 2022

    Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

    Active, not recruiting
    • Solid Tumor, Adult
    • +4 more
    • Birmingham, Alabama
    • +24 more
    Aug 5, 2022

    Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

    Completed
    • Small Cell Lung Cancer
    • +7 more
    • Scottsdale, Arizona
    • +4 more
    Jul 20, 2022

    Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma Trial in United

    Recruiting
    • Relapsed Chronic Lymphocytic Leukemia
    • +4 more
    • Phoenix, Arizona
    • +7 more
    Apr 28, 2022

    Systemic Therapies for R/R DLBCL

    Completed
    • Diffuse Large B Cell Lymphoma
      • Scottsdale, Arizona
      • +165 more
      Oct 12, 2021

      Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

      Completed
      Has Results
      • Diffuse Large B Cell Lymphoma
      • +4 more
      • Tucson, Arizona
      • +2 more
      Mar 23, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

      Terminated
      • Chronic Lymphocytic Leukemia
      • +7 more
      • Orange, California
      • +10 more
      Oct 15, 2020

      Diffuse Large B Cell Lymphoma Trial in United States (IMO-8400)

      Completed
      Has Results
      • Diffuse Large B Cell Lymphoma
      • Los Angeles, California
      • +11 more
      Nov 13, 2017

      Diffuse Large B Cell Lymphoma Trial in New York (rituximab, cyclophosphamide, vincristine)

      Completed
      Has Results
      • Diffuse Large B Cell Lymphoma
      • rituximab
      • +5 more
      • New York, New York
        Weill Cornell Medical College
      Feb 23, 2017